TCR2 Therapeutics Inc.
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
Last updated:
Abstract:
Provided herein are T cell receptor (TCR) fusion proteins (TFPs), T cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.
Status:
Application
Type:
Utility
Filling date:
13 Jun 2018
Issue date:
18 Mar 2021